Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Bugianesi

Showing results (141-150 of 326) with videos related to

Pageof 33
Sort By:
Journal of Clinical Medicine|May 7, 2020
Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel DiseasesLorenzo Bertani, Gian Paolo Caviglia, Luca Antonioli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 3, 2025
A European Survey to Identify Challenges in the Management of Metabolic Dysfunction-Associated Steatotic Liver DiseaseLaurent Castera, William Alazawi, Elisabetta Bugianesi, et al.
Biology|August 26, 2022
Changes in Liver Stiffness and Markers of Liver Synthesis and Portal Hypertension following Hepatitis C Virus Eradication in Cirrhotic IndividualsAngelo Armandi, Chiara Rosso, Giulia Troshina, et al.
Journal of Gastroenterology and Hepatology|September 29, 2011
Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver diseaseLeon A Adams, Jacob George, Elisabetta Bugianesi, et al.
Gut|July 30, 2025
Thrombospondin-2 is a performant biomarker of at-risk MASH and advanced MASH fibrosis in a large multicentre European cohortVlad Ratziu, Rambabu Surabattula, Elisabetta Bugianesi, et al.
Hepatology (Baltimore, Md.)|August 13, 2017
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistanceMelania Gaggini, Fabrizia Carli, Chiara Rosso, et al.
Frontiers in Nutrition|January 5, 2026
Soft drink consumption and liver fibrosis in type 2 diabetesArianna Ferro, Martina Bollati, Gian Paolo Caviglia, et al.
Gastroenterology|June 3, 2008
The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver diseaseLuca Miele, Gary Beale, Gillian Patman, et al.
International Journal of Molecular Sciences|December 3, 2020
Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein PGian Paolo Caviglia, Chiara Rosso, Angelo Armandi, et al.
Hepatology (Baltimore, Md.)|September 5, 2018
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisZobair Younossi, Frank Tacke, Marco Arrese, et al.
Pageof 33

Showing results (141-150 of 326) with videos related to

Sort By:
Pageof 33
Journal of Clinical Medicine|May 7, 2020
Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel DiseasesLorenzo Bertani, Gian Paolo Caviglia, Luca Antonioli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 3, 2025
A European Survey to Identify Challenges in the Management of Metabolic Dysfunction-Associated Steatotic Liver DiseaseLaurent Castera, William Alazawi, Elisabetta Bugianesi, et al.
Biology|August 26, 2022
Changes in Liver Stiffness and Markers of Liver Synthesis and Portal Hypertension following Hepatitis C Virus Eradication in Cirrhotic IndividualsAngelo Armandi, Chiara Rosso, Giulia Troshina, et al.
Journal of Gastroenterology and Hepatology|September 29, 2011
Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver diseaseLeon A Adams, Jacob George, Elisabetta Bugianesi, et al.
Gut|July 30, 2025
Thrombospondin-2 is a performant biomarker of at-risk MASH and advanced MASH fibrosis in a large multicentre European cohortVlad Ratziu, Rambabu Surabattula, Elisabetta Bugianesi, et al.
Hepatology (Baltimore, Md.)|August 13, 2017
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistanceMelania Gaggini, Fabrizia Carli, Chiara Rosso, et al.
Frontiers in Nutrition|January 5, 2026
Soft drink consumption and liver fibrosis in type 2 diabetesArianna Ferro, Martina Bollati, Gian Paolo Caviglia, et al.
Gastroenterology|June 3, 2008
The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver diseaseLuca Miele, Gary Beale, Gillian Patman, et al.
International Journal of Molecular Sciences|December 3, 2020
Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein PGian Paolo Caviglia, Chiara Rosso, Angelo Armandi, et al.
Hepatology (Baltimore, Md.)|September 5, 2018
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisZobair Younossi, Frank Tacke, Marco Arrese, et al.
Pageof 33